tosufloxacin has been researched along with Community Acquired Infection in 2 studies
tosufloxacin: quinolone anti-infective agent; structure given in first source
tosufloxacin : A racemate comprising equimolar amounts of (R)- and (S)-tosufloxacin.
7-(3-aminopyrrolidin-1-yl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid : A 1,8-naphthyridine derivative that is 4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid bearing additional 2,4-difluorophenyl, fluoro and 3-aminopyrrolidin-1-yl substituents at positions 1, 6 and 7 respectively.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yamaguchi, K | 1 |
| Kohno, S | 1 |
2 reviews available for tosufloxacin and Community Acquired Infection
| Article | Year |
|---|---|
Evaluation of in-vitro and in-vivo antibacterial activity of tosufloxacin tosilate.
Topics: Animals; Anti-Infective Agents; Chlamydia; Community-Acquired Infections; Disease Models, Animal; Fl | 2001 |
Clinical assessment of tosufloxacin tosilate.
Topics: Anti-Infective Agents; Community-Acquired Infections; Fluoroquinolones; Humans; Microbial Sensitivit | 2002 |